Amblyopia - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509246986

Publication Date:

September 23, 2024

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Amblyopia, likewise called "lazy eye," is the most widely recognized type of visual incapacity in youngsters. Human vision is poor during childbirth, yet enhances relentlessly during earliest stages and adolescence as connections amongst eye and cerebrum develop. Amblyopia is not an eye disease and it is not a sort of vision error that can be treated with glasses.
The global market for Amblyopia was estimated to be worth US$ 3935.8 million in 2023 and is forecast to a readjusted size of US$ 4712.5 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amblyopia, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Amblyopia by region & country, by Type, and by Application.
The Amblyopia market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amblyopia.
麻豆原创 Segmentation
By Company
Amblyoptica
Amblyotech
Good-Lite Co
Vivid Vision
Cooper Vision
Johnson & Johnson
Novartis AG
Carl Zeiss
HOYA Corporation
Krafty Eye Patches
Fresnel Prism and Lens
Hilco Vision
McKesson Corporation
Segment by Type:
Eye Patches
Atropine Drops
Glasses
Other
Segment by Application
Clinics
Hospitals
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Amblyopia manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Amblyopia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Amblyopia in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Amblyopia Product Introduction
1.2 Global Amblyopia 麻豆原创 Size Forecast
1.3 Amblyopia 麻豆原创 Trends & Drivers
1.3.1 Amblyopia Industry Trends
1.3.2 Amblyopia 麻豆原创 Drivers & Opportunity
1.3.3 Amblyopia 麻豆原创 Challenges
1.3.4 Amblyopia 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Amblyopia Players Revenue Ranking (2023)
2.2 Global Amblyopia Revenue by Company (2019-2024)
2.3 Key Companies Amblyopia Manufacturing Base Distribution and Headquarters
2.4 Key Companies Amblyopia Product Offered
2.5 Key Companies Time to Begin Mass Production of Amblyopia
2.6 Amblyopia 麻豆原创 Competitive Analysis
2.6.1 Amblyopia 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Amblyopia Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amblyopia as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Eye Patches
3.1.2 Atropine Drops
3.1.3 Glasses
3.1.4 Other
3.2 Global Amblyopia Sales Value by Type
3.2.1 Global Amblyopia Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Amblyopia Sales Value, by Type (2019-2030)
3.2.3 Global Amblyopia Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Other
4.2 Global Amblyopia Sales Value by Application
4.2.1 Global Amblyopia Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Amblyopia Sales Value, by Application (2019-2030)
4.2.3 Global Amblyopia Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Amblyopia Sales Value by Region
5.1.1 Global Amblyopia Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Amblyopia Sales Value by Region (2019-2024)
5.1.3 Global Amblyopia Sales Value by Region (2025-2030)
5.1.4 Global Amblyopia Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Amblyopia Sales Value, 2019-2030
5.2.2 North America Amblyopia Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Amblyopia Sales Value, 2019-2030
5.3.2 Europe Amblyopia Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Amblyopia Sales Value, 2019-2030
5.4.2 Asia Pacific Amblyopia Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Amblyopia Sales Value, 2019-2030
5.5.2 South America Amblyopia Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Amblyopia Sales Value, 2019-2030
5.6.2 Middle East & Africa Amblyopia Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Amblyopia Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Amblyopia Sales Value
6.3 United States
6.3.1 United States Amblyopia Sales Value, 2019-2030
6.3.2 United States Amblyopia Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Amblyopia Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Amblyopia Sales Value, 2019-2030
6.4.2 Europe Amblyopia Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Amblyopia Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Amblyopia Sales Value, 2019-2030
6.5.2 China Amblyopia Sales Value by Type (%), 2023 VS 2030
6.5.3 China Amblyopia Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Amblyopia Sales Value, 2019-2030
6.6.2 Japan Amblyopia Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Amblyopia Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Amblyopia Sales Value, 2019-2030
6.7.2 South Korea Amblyopia Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Amblyopia Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Amblyopia Sales Value, 2019-2030
6.8.2 Southeast Asia Amblyopia Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Amblyopia Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Amblyopia Sales Value, 2019-2030
6.9.2 India Amblyopia Sales Value by Type (%), 2023 VS 2030
6.9.3 India Amblyopia Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amblyoptica
7.1.1 Amblyoptica Profile
7.1.2 Amblyoptica Main Business
7.1.3 Amblyoptica Amblyopia Products, Services and Solutions
7.1.4 Amblyoptica Amblyopia Revenue (US$ Million) & (2019-2024)
7.1.5 Amblyoptica Recent Developments
7.2 Amblyotech
7.2.1 Amblyotech Profile
7.2.2 Amblyotech Main Business
7.2.3 Amblyotech Amblyopia Products, Services and Solutions
7.2.4 Amblyotech Amblyopia Revenue (US$ Million) & (2019-2024)
7.2.5 Amblyotech Recent Developments
7.3 Good-Lite Co
7.3.1 Good-Lite Co Profile
7.3.2 Good-Lite Co Main Business
7.3.3 Good-Lite Co Amblyopia Products, Services and Solutions
7.3.4 Good-Lite Co Amblyopia Revenue (US$ Million) & (2019-2024)
7.3.5 Vivid Vision Recent Developments
7.4 Vivid Vision
7.4.1 Vivid Vision Profile
7.4.2 Vivid Vision Main Business
7.4.3 Vivid Vision Amblyopia Products, Services and Solutions
7.4.4 Vivid Vision Amblyopia Revenue (US$ Million) & (2019-2024)
7.4.5 Vivid Vision Recent Developments
7.5 Cooper Vision
7.5.1 Cooper Vision Profile
7.5.2 Cooper Vision Main Business
7.5.3 Cooper Vision Amblyopia Products, Services and Solutions
7.5.4 Cooper Vision Amblyopia Revenue (US$ Million) & (2019-2024)
7.5.5 Cooper Vision Recent Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Profile
7.6.2 Johnson & Johnson Main Business
7.6.3 Johnson & Johnson Amblyopia Products, Services and Solutions
7.6.4 Johnson & Johnson Amblyopia Revenue (US$ Million) & (2019-2024)
7.6.5 Johnson & Johnson Recent Developments
7.7 Novartis AG
7.7.1 Novartis AG Profile
7.7.2 Novartis AG Main Business
7.7.3 Novartis AG Amblyopia Products, Services and Solutions
7.7.4 Novartis AG Amblyopia Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis AG Recent Developments
7.8 Carl Zeiss
7.8.1 Carl Zeiss Profile
7.8.2 Carl Zeiss Main Business
7.8.3 Carl Zeiss Amblyopia Products, Services and Solutions
7.8.4 Carl Zeiss Amblyopia Revenue (US$ Million) & (2019-2024)
7.8.5 Carl Zeiss Recent Developments
7.9 HOYA Corporation
7.9.1 HOYA Corporation Profile
7.9.2 HOYA Corporation Main Business
7.9.3 HOYA Corporation Amblyopia Products, Services and Solutions
7.9.4 HOYA Corporation Amblyopia Revenue (US$ Million) & (2019-2024)
7.9.5 HOYA Corporation Recent Developments
7.10 Krafty Eye Patches
7.10.1 Krafty Eye Patches Profile
7.10.2 Krafty Eye Patches Main Business
7.10.3 Krafty Eye Patches Amblyopia Products, Services and Solutions
7.10.4 Krafty Eye Patches Amblyopia Revenue (US$ Million) & (2019-2024)
7.10.5 Krafty Eye Patches Recent Developments
7.11 Fresnel Prism and Lens
7.11.1 Fresnel Prism and Lens Profile
7.11.2 Fresnel Prism and Lens Main Business
7.11.3 Fresnel Prism and Lens Amblyopia Products, Services and Solutions
7.11.4 Fresnel Prism and Lens Amblyopia Revenue (US$ Million) & (2019-2024)
7.11.5 Fresnel Prism and Lens Recent Developments
7.12 Hilco Vision
7.12.1 Hilco Vision Profile
7.12.2 Hilco Vision Main Business
7.12.3 Hilco Vision Amblyopia Products, Services and Solutions
7.12.4 Hilco Vision Amblyopia Revenue (US$ Million) & (2019-2024)
7.12.5 Hilco Vision Recent Developments
7.13 McKesson Corporation
7.13.1 McKesson Corporation Profile
7.13.2 McKesson Corporation Main Business
7.13.3 McKesson Corporation Amblyopia Products, Services and Solutions
7.13.4 McKesson Corporation Amblyopia Revenue (US$ Million) & (2019-2024)
7.13.5 McKesson Corporation Recent Developments
8 Industry Chain Analysis
8.1 Amblyopia Industrial Chain
8.2 Amblyopia Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Amblyopia Sales Model
8.5.2 Sales Channel
8.5.3 Amblyopia Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Amblyoptica
Amblyotech
Good-Lite Co
Vivid Vision
Cooper Vision
Johnson & Johnson
Novartis AG
Carl Zeiss
HOYA Corporation
Krafty Eye Patches
Fresnel Prism and Lens
Hilco Vision
McKesson Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.